KIR3DL3 Antibody
-
中文名稱：KIR3DL3兔多克隆抗體
-
貨號：CSB-PA850818ESR1HU
-
規格：￥440
-
圖片：
-
Western blot
All lanes: KIR3DL3 antibody at 1.75µg/ml + Jurkat whole cell lysate
Secondary
Goat polyclonal to rabbit IgG at 1/10000 dilution
Predicted band size: 45 kDa
Observed band size: 45 kDa -
Immunohistochemistry of paraffin-embedded human tonsil tissue using CSB-PA850818ESR1HU at dilution of 1:100
-
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) KIR3DL3 Polyclonal antibody
-
Uniprot No.：
-
基因名：
-
別名：CD158 antigen-like family member Z antibody; CD158z antibody; KI3L3_HUMAN antibody; Killer cell immunoglobulin-like receptor 3DL3 antibody; Killer cell inhibitory receptor 1 antibody; KIR3DL3 antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Recombinant Human Killer cell immunoglobulin-like receptor 3DL3 protein (26-322AA)
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：Antigen Affinity Purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
-
產品提供形式：Liquid
-
應用范圍：ELISA, WB, IHC
-
推薦稀釋比：
Application Recommended Dilution WB 1:1000-1:5000 IHC 1:20-1:200 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Receptor on natural killer cells. May inhibit the activity of NK cells thus preventing cell lysis.
-
亞細胞定位：Cell membrane; Single-pass type I membrane protein.
-
蛋白家族：Immunoglobulin superfamily
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
